Oskar Ragnarsson

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. doi request reprint Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease
    Charlotte Hoybye
    Department of Endocrinology, Karolinska University Hospital, Solna, SE 171 76 Stockholm, Sweden
    Eur J Endocrinol 162:677-84. 2010
  2. doi request reprint Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden
    Eur J Endocrinol 169:211-5. 2013
  3. doi request reprint Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE 413 45 Goteborg, Sweden
    J Clin Endocrinol Metab 97:E1640-8. 2012
  4. doi request reprint Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood
    Oskar Ragnarsson
    Department of Endocrinology, Sahlgrenska University Hospital and University of Gothenburg, Grona Straket 8, Gothenburg, Sweden
    Eur J Endocrinol 166:593-600. 2012
  5. doi request reprint Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism
    Oskar Ragnarsson
    Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Goteborg, Sweden
    Clin Endocrinol (Oxf) 76:246-52. 2012
  6. doi request reprint Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency
    Helena Filipsson Nyström
    Department of Endocrinology, Sahlgrenska University Hospital, and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE 41345 Goteborg, Sweden
    J Clin Endocrinol Metab 97:3185-95. 2012
  7. doi request reprint Effect of short-term GH and testosterone administration on body composition and glucose homoeostasis in men receiving chronic glucocorticoid therapy
    Oskar Ragnarsson
    Department of Endocrinology, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Grona Straket 8, SE 413 45 Goteborg, Sweden
    Eur J Endocrinol 168:243-51. 2013

Detail Information

Publications7

  1. doi request reprint Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease
    Charlotte Hoybye
    Department of Endocrinology, Karolinska University Hospital, Solna, SE 171 76 Stockholm, Sweden
    Eur J Endocrinol 162:677-84. 2010
    ..In this study, we evaluated the features of GHD in a large cohort of controlled CD patients, and assessed the effect of GH treatment...
  2. doi request reprint Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden
    Eur J Endocrinol 169:211-5. 2013
    ..The aim of this study was to analyze neurodegenerative and inflammatory biomarkers in the CSF of patients with CS in remission...
  3. doi request reprint Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE 413 45 Goteborg, Sweden
    J Clin Endocrinol Metab 97:E1640-8. 2012
    ..Cognitive function is impaired in patients with active Cushing's syndrome (CS)...
  4. doi request reprint Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood
    Oskar Ragnarsson
    Department of Endocrinology, Sahlgrenska University Hospital and University of Gothenburg, Grona Straket 8, Gothenburg, Sweden
    Eur J Endocrinol 166:593-600. 2012
    ..Cushing's disease (CD) and non-functioning pituitary adenoma (NFPA) are rare in paediatric patients. The aim of this study was to describe long-term consequences in adults with GH deficiency (GHD) treated for CD or NFPA during childhood...
  5. doi request reprint Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism
    Oskar Ragnarsson
    Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Goteborg, Sweden
    Clin Endocrinol (Oxf) 76:246-52. 2012
    ..The objective of this study was to analyse the effects of glucocorticoid (GC) replacement on cardiovascular risk factors and BMD in patients with hypopituitarism...
  6. doi request reprint Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency
    Helena Filipsson Nyström
    Department of Endocrinology, Sahlgrenska University Hospital, and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE 41345 Goteborg, Sweden
    J Clin Endocrinol Metab 97:3185-95. 2012
    ..Adult GH deficiency (GHD) is associated with impaired quality of life (QoL) and increased cardiovascular risk. Continued long-term efficacy in terms of QoL and cardiovascular risk factors has been indicated in open surveillance studies...
  7. doi request reprint Effect of short-term GH and testosterone administration on body composition and glucose homoeostasis in men receiving chronic glucocorticoid therapy
    Oskar Ragnarsson
    Department of Endocrinology, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Grona Straket 8, SE 413 45 Goteborg, Sweden
    Eur J Endocrinol 168:243-51. 2013
    ..The objective of this study was to investigate whether short-term treatment with GH and testosterone (T) can increase lean mass without major impairment of glucose homoeostasis in patients on GC therapy...